SI0983995T1 - Pharmaceutically-active dimethyl-(3-aryl-but-3-enyl)-amine compounds - Google Patents

Pharmaceutically-active dimethyl-(3-aryl-but-3-enyl)-amine compounds

Info

Publication number
SI0983995T1
SI0983995T1 SI9730653T SI9730653T SI0983995T1 SI 0983995 T1 SI0983995 T1 SI 0983995T1 SI 9730653 T SI9730653 T SI 9730653T SI 9730653 T SI9730653 T SI 9730653T SI 0983995 T1 SI0983995 T1 SI 0983995T1
Authority
SI
Slovenia
Prior art keywords
enyl
aryl
pharmaceutically
amine compounds
active dimethyl
Prior art date
Application number
SI9730653T
Other languages
English (en)
Slovenian (sl)
Inventor
Helmut Heinrich Dr. Buschmann
Wolfgang Werner Alfred Prof. Dr. Strassburger
Babette-Yvonne Dr. Koegel
Elmar Josef Dr. Friedrichs
Original Assignee
Gruenenthal Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gruenenthal Gmbh filed Critical Gruenenthal Gmbh
Publication of SI0983995T1 publication Critical patent/SI0983995T1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
    • C07D333/54—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C211/00—Compounds containing amino groups bound to a carbon skeleton
    • C07C211/01—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms
    • C07C211/26—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing at least one six-membered aromatic ring
    • C07C211/28—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing at least one six-membered aromatic ring having amino groups linked to the six-membered aromatic ring by unsaturated carbon chains
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C211/00—Compounds containing amino groups bound to a carbon skeleton
    • C07C211/01—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms
    • C07C211/26—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing at least one six-membered aromatic ring
    • C07C211/29—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing at least one six-membered aromatic ring the carbon skeleton being further substituted by halogen atoms or by nitro or nitroso groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
    • C07C215/46—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C215/48—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by hydroxy groups
    • C07C215/54—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by hydroxy groups linked by carbon chains having at least three carbon atoms between the amino groups and the six-membered aromatic ring or the condensed ring system containing that ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
    • C07C215/46—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C215/64—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with rings other than six-membered aromatic rings being part of the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/54—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C217/56—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by singly-bound oxygen atoms
    • C07C217/62—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by singly-bound oxygen atoms linked by carbon chains having at least three carbon atoms between the amino groups and the six-membered aromatic ring or the condensed ring system containing that ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/54—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C217/74—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with rings other than six-membered aromatic rings being part of the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C219/00—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton
    • C07C219/26—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C219/28—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton having amino groups bound to acyclic carbon atoms of the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07—Optical isomers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
    • C07C2601/10—Systems containing only non-condensed rings with a five-membered ring the ring being unsaturated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/16—Systems containing only non-condensed rings with a six-membered ring the ring being unsaturated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Rheumatology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
SI9730653T 1996-03-13 1997-02-22 Pharmaceutically-active dimethyl-(3-aryl-but-3-enyl)-amine compounds SI0983995T1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19609847A DE19609847A1 (de) 1996-03-13 1996-03-13 Dimethyl-(3-aryl-but-3-enyl)-aminverbindungen als pharmazeutische Wirkstoffe
EP99119109A EP0983995B1 (de) 1996-03-13 1997-02-22 Dimethyl-(3-aryl-but-3-enyl)-aminverbindungen als pharmazeutische Wirkstoffe

Publications (1)

Publication Number Publication Date
SI0983995T1 true SI0983995T1 (en) 2004-10-31

Family

ID=7788151

Family Applications (3)

Application Number Title Priority Date Filing Date
SI9730653T SI0983995T1 (en) 1996-03-13 1997-02-22 Pharmaceutically-active dimethyl-(3-aryl-but-3-enyl)-amine compounds
SI9730618T SI1069106T1 (en) 1996-03-13 1997-02-22 Dimethyl-(3-aryl-but-3-enyl) amine derivatives with analgesic activity
SI9730428T SI0799819T1 (en) 1996-03-13 1997-02-22 1-Dimethylaminomethyl 2-phenyl cycloalk-2-ene derivatives with analgesic activity

Family Applications After (2)

Application Number Title Priority Date Filing Date
SI9730618T SI1069106T1 (en) 1996-03-13 1997-02-22 Dimethyl-(3-aryl-but-3-enyl) amine derivatives with analgesic activity
SI9730428T SI0799819T1 (en) 1996-03-13 1997-02-22 1-Dimethylaminomethyl 2-phenyl cycloalk-2-ene derivatives with analgesic activity

Country Status (27)

Country Link
US (1) US5811582A (cs)
EP (4) EP0799819B1 (cs)
JP (2) JP4205182B2 (cs)
KR (2) KR100538662B1 (cs)
CN (1) CN1157366C (cs)
AR (1) AR008991A1 (cs)
AT (3) ATE258544T1 (cs)
AU (1) AU725430B2 (cs)
BR (1) BR9700369B1 (cs)
CA (1) CA2199679C (cs)
CO (1) CO4520279A1 (cs)
CZ (1) CZ293971B6 (cs)
DE (4) DE19609847A1 (cs)
DK (3) DK1069106T3 (cs)
ES (3) ES2218924T3 (cs)
HU (1) HU224819B1 (cs)
IL (1) IL120430A (cs)
NO (1) NO308294B1 (cs)
NZ (1) NZ314384A (cs)
PE (1) PE55798A1 (cs)
PL (1) PL186050B1 (cs)
PT (3) PT983995E (cs)
RU (1) RU2167146C2 (cs)
SI (3) SI0983995T1 (cs)
SK (1) SK284328B6 (cs)
UA (1) UA55373C2 (cs)
ZA (1) ZA972147B (cs)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4426245A1 (de) 1994-07-23 1996-02-22 Gruenenthal Gmbh 1-Phenyl-3-dimethylamino-propanverbindungen mit pharmakologischer Wirkung
DE19732928C2 (de) * 1997-07-31 2000-05-18 Gruenenthal Gmbh Verwendung substituierter Imidazolidin-2,4-dion-Verbindungen als Schmerzmittel
DE19830105C1 (de) * 1998-07-06 2000-02-17 Gruenenthal Gmbh Acridinderivate
ES2141688B1 (es) * 1998-11-06 2001-02-01 Vita Invest Sa Nuevos esteres derivados de compuestos fenil-ciclohexil sustituidos.
DE10000311A1 (de) * 2000-01-05 2001-07-12 Gruenenthal Gmbh Aminomethyl-Phonyl-Cyclohexanonderivate
DE10025948A1 (de) * 2000-05-26 2001-11-29 Gruenenthal Gmbh Wirkstoffkombination
DE10049483A1 (de) † 2000-09-29 2002-05-02 Gruenenthal Gmbh Substituierte 1-Aminobutan-3-ol-Derivate
DE10049481A1 (de) * 2000-09-29 2002-05-02 Gruenenthal Gmbh Substituierte C-Cyclohexylmethylamin-Derivate
DE10059413A1 (de) * 2000-11-30 2002-06-20 Gruenenthal Gmbh Verwendung von substituierten 6-Dimethylaminomethyl-1-phenyl-cyclohexanverbindungen zur Therapie der Harninkontinenz
DE10059411A1 (de) * 2000-11-30 2002-06-13 Gruenenthal Gmbh Verwendung von 6-Dimethylaminomethyl-1-phenyl-cyclohexanverbindungen zur Therapie der Harninkontinenz
US20050176790A1 (en) 2001-02-28 2005-08-11 Johannes Bartholomaus Pharmaceutical salts
JP4377585B2 (ja) 2001-03-16 2009-12-02 ディーエムアイ バイオサイエンシズ インコーポレイテッド 射精遅延の方法
DE10132747A1 (de) * 2001-07-05 2003-01-23 Gruenenthal Gmbh Substituierte 1-Aryl-but-3-enylamin- und 1-Aryl-but-2-enylaminverbindungen
DE10146275A1 (de) * 2001-09-18 2003-04-24 Gruenenthal Gmbh Kombination ausgewählter Opioide mit Muscarin-Antagonisten zur Therapie der Harninkontinenz
PE20030527A1 (es) 2001-10-24 2003-07-26 Gruenenthal Chemie Formulacion farmaceutica con liberacion retardada que contiene 3-(3-dimetilamino-1-etil-2-metil-propil) fenol o una sal farmaceuticamente aceptable del mismo y tabletas para administracion oral que la contienen
DE10224624A1 (de) * 2002-05-30 2003-12-11 Gruenenthal Gmbh Metabolite und Prodrugs von 1-Dimethylamino-3-(3-methoxy-phenyl)-2-methyl-pentan-3-ol
DE10225315A1 (de) * 2002-06-06 2003-12-24 Gruenenthal Gmbh Wirkstoffsalze und Ester von 1-Dimethylamino-3-(3-methoxy-phenyl)-2-methyl- pentan-3-ol und 3-(3-Dimethylamino-1-ethyl-1-hydroxy-2-methyl- propyl)-phenol
DE10261091A1 (de) 2002-12-20 2004-07-01 Grünenthal GmbH Gesättigte und ungesättigte Heteroarylcycloalkylmethyl-Amine
DE10315917A1 (de) * 2003-04-08 2004-11-18 Schwarz Pharma Ag Hochreine Basen von 3,3-Diphenylpropylaminmonoestern
DE10326097A1 (de) * 2003-06-06 2005-01-05 Grünenthal GmbH Verfahren zur Herstellung von Dimethyl-(3-aryl-butyl)-aminverbindungen
DE10328316A1 (de) * 2003-06-23 2005-01-20 Grünenthal GmbH Verfahren zur Herstellung von Dimethyl-(3-aryl-buthyl)-aminverbindungen als pharmazeutische Wirkstoffe
DE102004034619A1 (de) * 2004-07-16 2006-02-23 Grünenthal GmbH Substituierte Aminoverbindungen als 5-HT/NA Uptakehemmer
DE102005033732B4 (de) 2005-05-27 2014-02-13 Grünenthal GmbH Trennung stereoisomerer N,N-Dialkylamino-2-alkyl-3-hydroxy-3-phenyl-alkane
DE102005052588A1 (de) 2005-11-02 2007-05-10 Grünenthal GmbH Verfahren zur Herstellung substituierter Dimethyl-(3-aryl-butyl)-amin-Verbindungen mittels homogener Katalyse
DE102005061429A1 (de) * 2005-12-22 2007-06-28 Grünenthal GmbH Substituierte Oxazol-Derivate
JP5208933B2 (ja) * 2006-07-24 2013-06-12 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ （２ｒ，３ｒ）−３−（３−メトキシフェニル）−ｎ，ｎ，２−トリメチルペンタナミンの製造
TWI448447B (zh) * 2006-07-24 2014-08-11 Gruenenthal Chemie 製備（１ｒ，２ｒ）-３-（３-二甲胺基-１-乙基-２-甲基-丙基）-酚之方法
CN101948397A (zh) * 2010-09-07 2011-01-19 天津泰普药品科技发展有限公司 镇痛药他喷他多重要中间体的制备方法
EP2619174A4 (en) * 2010-09-20 2014-05-14 Ind Swift Lab Ltd PROCESS FOR THE PREPARATION OF L-PHENYL-3-DIMETHYLAMINOPROPANE DERIVATIVES
EP2674414A1 (en) 2012-06-15 2013-12-18 Siegfried AG Method for the preparation of 1-aryl-1-alkyl-3-dialkylaminopropane compounds

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1518663A1 (de) * 1965-08-02 1969-12-18 Gruenenthal Chemie Basisch substituierte Cycloalken-derivate und Verfahren zu ihrer Herstellung
US3652589A (en) * 1967-07-27 1972-03-28 Gruenenthal Chemie 1-(m-substituted phenyl)-2-aminomethyl cyclohexanols
US3978129A (en) * 1972-01-28 1976-08-31 A. H. Robins Company, Incorporated Alkenyl- and alkanylamines
NL7403348A (cs) * 1973-03-19 1974-09-23
GB1502635A (en) * 1974-02-27 1978-03-01 Schering Ag Process for splitting steroid ethers
DE2409990C2 (de) * 1974-02-27 1982-11-25 Siemens AG, 1000 Berlin und 8000 München Meßwandler für Hochspannungsschaltanlagen mit Metallkapselung
JPS598259B2 (ja) * 1976-01-01 1984-02-23 武田薬品工業株式会社 新規シクロヘキセン誘導体
US4173649A (en) * 1978-02-27 1979-11-06 E. R. Squibb & Sons, Inc. 5-Phenyl-2,4-pentadien-1-amines and method for inhibiting prostaglandin dehydrogenase
FR2559765B1 (fr) * 1984-02-16 1986-06-13 Rhone Poulenc Sante Nouveaux derives de la phenyl-3 propene-2 amine, leur preparation et les medicaments qui les contiennent
IT1213219B (it) * 1984-09-28 1989-12-14 Consiglio Nazionale Ricerche Derivati amminoalchilnaftalenici ad attivita' farmacologica.
US5430044A (en) * 1987-02-06 1995-07-04 Fisons Corporation Arylalkyl-amines and -amides having anticonvulsant and neuroprotective properties
SE9202218D0 (sv) * 1992-07-22 1992-07-22 Kabi Pharmacia Ab Pharmacologically active alfa-(tertiary-aminomethyl)-benzenemethanol derivatives, pharmaceutical composition containing them, therapeutical use thereof and processes for their preparation
DE4426245A1 (de) * 1994-07-23 1996-02-22 Gruenenthal Gmbh 1-Phenyl-3-dimethylamino-propanverbindungen mit pharmakologischer Wirkung

Also Published As

Publication number Publication date
SK284328B6 (sk) 2005-01-03
HK1031864A1 (en) 2001-06-29
KR100602810B1 (ko) 2006-07-20
HUP9700574A2 (hu) 1998-10-28
JP2008273937A (ja) 2008-11-13
ATE223888T1 (de) 2002-09-15
EP1069106A2 (de) 2001-01-17
EP0799819A1 (de) 1997-10-08
ES2183030T3 (es) 2003-03-16
ES2213526T3 (es) 2004-09-01
HU9700574D0 (en) 1997-04-28
DK1069106T3 (da) 2004-04-19
EP0983995A3 (de) 2001-01-10
UA55373C2 (uk) 2003-04-15
NZ314384A (en) 1999-06-29
SI0799819T1 (en) 2003-02-28
NO971137D0 (no) 1997-03-12
BR9700369A (pt) 1998-10-27
SI1069106T1 (en) 2004-04-30
DE59711477D1 (de) 2004-05-06
DK0799819T3 (da) 2002-12-02
JP4846750B2 (ja) 2011-12-28
KR970065504A (ko) 1997-10-13
CN1157366C (zh) 2004-07-14
RU2167146C2 (ru) 2001-05-20
DE59708160D1 (de) 2002-10-17
ZA972147B (en) 1997-09-17
DE19609847A1 (de) 1997-09-18
ATE258544T1 (de) 2004-02-15
EP0983994A2 (de) 2000-03-08
CZ75997A3 (cs) 1998-04-15
AU725430B2 (en) 2000-10-12
PT1069106E (pt) 2004-06-30
DK0983995T3 (da) 2004-05-24
EP0983995B1 (de) 2004-03-31
KR100538662B1 (ko) 2006-03-28
MX9701865A (es) 1997-09-30
JPH107624A (ja) 1998-01-13
AR008991A1 (es) 2000-03-08
EP0799819B1 (de) 2002-09-11
BR9700369B1 (pt) 2009-01-13
NO971137L (no) 1997-09-15
HU224819B1 (en) 2006-02-28
CA2199679C (en) 2005-07-05
EP1069106B1 (de) 2004-01-28
IL120430A (en) 2001-01-28
EP1069106A3 (de) 2001-01-24
US5811582A (en) 1998-09-22
HUP9700574A3 (en) 2000-01-28
PT983995E (pt) 2004-08-31
PE55798A1 (es) 1998-10-24
EP0983994A3 (de) 2001-01-10
PL318922A1 (en) 1997-09-15
DE59711267D1 (de) 2004-03-04
HK1026197A1 (en) 2000-12-08
PL186050B1 (pl) 2003-09-30
ES2218924T3 (es) 2004-11-16
CZ293971B6 (cs) 2004-09-15
CN1163884A (zh) 1997-11-05
ATE263140T1 (de) 2004-04-15
EP0983995A2 (de) 2000-03-08
CA2199679A1 (en) 1997-09-13
PT799819E (pt) 2003-01-31
IL120430A0 (en) 1997-07-13
SK32197A3 (en) 1997-12-10
AU1625197A (en) 1997-09-18
CO4520279A1 (es) 1997-10-15
JP4205182B2 (ja) 2009-01-07
NO308294B1 (no) 2000-08-28

Similar Documents

Publication Publication Date Title
SI0983995T1 (en) Pharmaceutically-active dimethyl-(3-aryl-but-3-enyl)-amine compounds
GB9605548D0 (en) Packaging
TW468619U (en) Package
GB9407989D0 (en) New packages
GB9614114D0 (en) New packages
GB9613372D0 (en) Package
ZA972173B (en) Spreader
GB9603889D0 (en) Packaging
GB2307390B (en) Spreader
GB2319242B (en) Packaging
GB9600725D0 (en) Pharmaceutically-active compounds
GB9600551D0 (en) Pharmaceutically-active compounds
GB9416956D0 (en) Pharmaceutically-active compounds
GB9424210D0 (en) Pharmaceutically-active compounds
GB9417545D0 (en) Pharmaceutically-active compounds
GB9417321D0 (en) Pharmaceutically-active compounds
GB9409563D0 (en) Pharmaceutically-active compounds
GB9408554D0 (en) Pharmaceutically-active compounds
GB9605803D0 (en) Pharmaceutically-active compound
GB9605826D0 (en) Packaging
GB9500806D0 (en) Pharmaceutically-active compounds
GB9500681D0 (en) Pharmaceutically-active compounds
GB9517916D0 (en) Pharmaceutically-active compounds
CA77967S (en) Package
GB9609631D0 (en) New Packages